source
- Natera partners with Angiex to evaluate Signatera blood test in AGX101 cancer trialNatera announced a collaboration with biotech Angiex to assess its Signatera circulating tumor DNA blood test in the context of Angiex’s early‑stage clinical trial of AGX101. Angiex, based in Camb…
- Pregnancy hormone explored as possible guide for cardiovascular drug developmentThe STAT+ newsletter preview highlights a discussion about whether a hormone that regulates pregnancy could be leveraged to direct a new cardiovascular therapy. The piece also notes that researche…